Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 6/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.42 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 2/20 | 0.38 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.38 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | ARG1 | P05089 | 1/20 | 0.36 |
| ▸ | ARG2 | P78540 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6364468 | 0.89 | KIF11 (0.50) | KIF11TAAR1MAOASLC6A2SMN1; SMN2 | |
| SCHEMBL7491955 | 0.83 | MAOA (0.52) | KIF11TAAR1MAOASLC6A2SMN1; SMN2 | |
| SCHEMBL7497898 | 0.81 | MAOA (0.50) | KIF11TAAR1MAOASLC6A2SMN1; SMN2 | |
| SCHEMBL28744986 | 0.81 | MAOA (0.50) | KIF11TAAR1MAOASLC6A2SMN1; SMN2 | |
| SCHEMBL9182645 | 0.81 | MAOA (0.50) | KIF11TAAR1MAOASLC6A2SMN1; SMN2 | |
| SCHEMBL27295811 | 0.81 | MAOA (0.50) | KIF11TAAR1MAOASLC6A2SMN1; SMN2 | |
| SCHEMBL4552971 | 0.77 | TAAR1 (0.52) | KIF11TAAR1MAOASLC6A2SMN1; SMN2 | |
| SCHEMBL21880069 | 0.75 | KIF11 (0.52) | KIF11TAAR1MAOASLC6A2SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL4650598 | 0.75 | TAAR1 (0.50) | KIF11TAAR1MAOASLC6A2SMN1; SMN2 | |
| SCHEMBL14346444 | 0.75 | KIF11 (0.38) | KIF11TAAR1MAOASLC6A2HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | Wurster, Siegfried (FI) | 2010-02-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048549-A1 | Peptidomimetics selective for the somatostatin receptor subtypes 1 and/or 4 | SSTR1, SSTR4, SSTR3 | KIF11 2691/4885TAAR1 63/4885MAOA 3631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.